This article is part of “ Innovations In: RSV ,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca .
While pregnant with her third child last year, Alison Carroll pondered options that hadn’t been available during her first two pregnancies: not one but two ways to help prevent her newborn from ending up in the hospital, fighting for breath because of a severe infection with respiratory syncytial virus (RSV).
A pediatric hospitalist herself, she already had for years witnessed and treated the worst of RSV’s ravages in children, including a scary situation that landed her own daughter, Stella, in the same wing of Vanderbilt Children’s Hospital in Nashville, where Carroll works.
Source:
